Early Access — free while we kick the tires
EdgarHawk

Roberts David B

President and Director

Director Officer
2 filings analyzed · 1 company · Latest 2026-03-02

Companies

Company Buys Sells Direction
LEMAITRE VASCULAR INC LMAT 0 12 Net selling

Activity

March 2026
2026-03-02 LEMAITRE VASCULAR INC LMAT
medium
Sell
8,464 shares
$903,958
Significance 5/10

LMAT President Roberts David B sold 8,464 shares at $106.80; reduces stake to 17,979 shares (-32.0%)

Roberts David B, President and Director, sold 8,464 shares of LMAT at $106.80 for $903,957.74, reducing his holdings by 32.0% from 26,443 to 17,979 shares. The sale occurred near the stock's recent high of $113.69, with the current price at $107.40, placing the transaction only 5.5% below the 52-week peak and following a 26.4% gain over the preceding 30 days. His prior four sales at this ticker occurred on the same date cluster in August 2025, three of which showed negative 90-day returns—indicating a pattern of well-timed exits at LMAT. LMAT's fundamentals show strong recent performance: Revenue of $61.0M and net income of $17.4M in the latest quarter, with annual revenue growth of 13.5%, though the P/E of 36.53 reflects a premium valuation. The substantial reduction in his personal stake warrants monitoring of whether this reflects portfolio adjustments or broader confidence shifts in the company's forward trajectory.

August 2025
2025-08-13 LEMAITRE VASCULAR INC LMAT
medium
Sell
10,815 shares
$999,173
Significance 6/10

President David Roberts sold 10,815 shares at blended avg $92.39 on 2025-08-11 ($999.2K); stock now $95.15

Roberts executed 3 separate sales on 2025-08-11 totaling 10,815 shares for $999,173.33, reducing his holdings by 37.6% from 28,791 to 17,976 shares. The sales occurred at prices ranging from $91.55 to $92.53 (blended average $92.39), while current price is $95.15, suggesting the timing was notably suboptimal—the stock has appreciated 2.8% since these transactions. His prior 5 sales at LMAT show mixed outcomes: 4 of 5 generated positive 90-day returns (ranging +1.3% to +4.4%), with only 1 of 5 classified as well-timed; this suggests his historical execution at this ticker has generally lagged subsequent price action. The company shows solid fundamentals (FY revenue growth +13.6%, P/E 45.75, $13.8M recent quarterly net income), though the stock trades 11.9% below its 52-week high despite recent 30-day and 90-day momentum of +13.2% and +14.2% respectively. The substantial reduction in his direct ownership stake warrants tracking whether this signals strategic repositioning or other considerations.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access